GLOBAL HEALTH WORKING GROUP
Focus on Africa: The Resilience of Survivors Jennyfer Ambe Co-Chair WCAPS Global Health Working Group ES ECEPAS Working Group, The GET Consortium April 3rd 2020 Acknowledgements: Yusuf Kabba, President SLAES, Freetown, Sierra Leone Photos Courtesy of Pa Sesay, Freetown, Sierra Leone As a researcher, this article could easily have been on How are Vulnerable populations affected by Epidemics and Pandemics or What impact has COVID-19 had on vulnerable populations? These are key questions many are asking and will be tackled in due course. For now I will put a pause on that and share a story of resilience and hope. In West Africa, the countries of Guinea, Sierra Leone and Liberia, suffered catastrophic loss of life. There was also a huge economic blow to the Economic Community of West African States (ECOWAS) during the Ebola Virus Disease (EVD) outbreak which started in December 2013 and lasted until June 2016. The outbreak left over 10,000 orphans across the region with approximately 11,310 deaths.1 The Ethics, Community Engagement and Patient Advocacy Support (ECEPAS) working group of the Global Emerging Pathogens Treatment (GET) Consortium were actively involved in bioethics reviews of protocols for research.2 At the same time researchers were involved in the convalescent plasma clinical trials to find out if the antibodies from recovered patients could be used to help others. Some of the survivors were integrated as part of the ECEPAS working group. Members engaged with stakeholders in the region assisting with humanitarian and psycho-social needs, supporting the building of a network of survivors within each 1
Situation Report. Ebola Virus Disease. (2016, June 10). World Health Organization. Kombe et al. (2015). Taking the bull by the horns: ethical consideration in the design and implementation of an ebola virus therapy trail. Social Science and Medicine. 2